• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

Catch a virus by its tail

Bioengineer by Bioengineer
May 13, 2019
in Immunology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Study uncovers key mechanism that allows some of the world’s deadliest viruses to replicate

Viruses are masterful invaders. They cannibalize host cells by injecting their genetic material, often making thousands of copies of themselves in a single cell to ensure their replication and survival.

Some RNA viruses insert their genetic material as a single piece, while others chop it up into pieces. The latter are aptly named segmented viruses.

Such segmented RNA viruses–including several that cause human diseases like influenza–have been a longstanding enigma to researchers: How do they accomplish the precise copying and insertion of each segment? How do they ensure that individual segments are all copied by the same enzyme while ensuring that each segment can make different amounts of RNA? Such exquisite regulation is critical to make the correct levels of the viral proteins necessary for successful replication.

Now research by scientists at Harvard Medical School’s Blavatnik Institute yields a surprising answer: The viral machinery in charge of this survival-ensuring maneuver becomes activated by an RNA from the opposite end of the segment where copying starts.

The findings, published May 9 in PNAS, identify new potential targets to inhibit the replication of segmented viruses. This group includes several emerging and highly fatal viruses such as Lassa fever virus, bunyaviruses like La Crosse and Rift Valley fever, as well as the better known and more common influenza viruses.

“Climate change has altered and intensified the spread of some serious and emerging viruses to new geographic regions, creating an acute challenge to global health. Our findings identify a critical mechanism that allows some of these pathogens to replicate and survive,” said Sean P. J. Whelan, professor of microbiology at HMS and director of the Harvard Program in Virology.

Lassa fever infections, for example, are rarely fatal, but once actual disease develops, it can cause hemorrhages, or bleeding, in multiple organs in one out of five people. The mortality rate can reach 50 percent during epidemics, according to the Centers for Disease Control and Prevention.

In the study, Whelan and study co-author Jesse Pyle, a graduate student in Whelan’s lab, worked with the Machupo virus, an arenavirus, which like Lassa virus infects rodents that in turn transmit the virus to humans where it causes fatal hemorrhagic fevers.

Unlike the flu virus, whose genome has eight segments, Machupo virus has only two segments–called small and large segments–offering a much simpler way to understand how different segments are copied in the correct amounts.

Previous clues about this mechanism came from research on influenza and La Crosse viruses that showed the viral protein responsible for copying the key segment–RNA-dependent RNA-polymerase (RdRP)–interacts with the 5′ end of the segment, which is the exact opposite end to the location where the protein initiates copying. Yet, the importance of this interaction was not fully understood.

The experiments revealed that mixing short 13-nucleotide long RNAs from the 5′ end of the Machupo virus segments with the RdRP–the catalyst that initiates RNA replication–in fact, stimulated the ability of this enzyme to copy the viral segment. The two-segment Machupo virus contains four subtly different 5′ RNAs that each bind the RdRP enzyme. Remarkably, the scientists observed, those RNAs dictate which of the four different start sites the enzyme actually uses.

Whelan and Pyle say these results not only shed light on an important question in basic virology, but they also identify a new target that may illuminate how to develop of a new class of antiviral drugs that target this essential 5′ RNA activation.

Most antiviral drugs currently on the market directly target viral enzymes involved in replicating genetic material or in the processing of viral proteins. None, however, interfere with the particular mechanism described in the current study.

“Our work demonstrates that both the 5′ RNA and its binding site on the viral enzyme are potential new targets for inhibition of viral replication,” Whelan said. “An important next goal would be to hunt for molecules that interfere with this process and set the stage for new drug design.”

###

This research was funded by National Institutes of Health (grants AI133689, T32AI007245 and AI059371).

Paper DOI:
https://doi.org/10.1073/pnas.1900790116

Media Contact
Ekaterina Pesheva
[email protected]
http://dx.doi.org/10.1073/pnas.1900790116

Tags: Climate ChangeInfectious/Emerging DiseasesMedicine/HealthMicrobiologyVirology
Share12Tweet7Share2ShareShareShare1

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    123 shares
    Share 49 Tweet 31
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    76 shares
    Share 30 Tweet 19
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    52 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring Costochondral Junction Variations in Young Children

New Biomarkers Uncover Cardiovascular Disease Risk in Type 2 Diabetes

New Biomarkers Uncover Cardiovascular Disease Risk in Type 2 Diabetes

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.